• Role of HSCT vs CAR T cells in Hematologic Malignancy
A/Prof. Kitsada Wudhikarn, Division of Hematology, Faculty of Medicine, Chulalongkorn University, Thailand

• Challenges in delivering cellular therapies for transplant recipients and cancer patients
Prof. Rajiv Khanna, Co-Director, Queensland Immunology Research Centre; Distinguished Scientist, Tumour Immunology Laboratory, QIMR Berghofer Medical Research Institute, Australia

• mRNA-based T cell engineering for treatment of virus-related cancer and virus infection
Prof. Antonio Bertoletti, Duke-NUS Graduate Medical School, Singapore

• Clinical Application of Mesenchymal Stem Cells: Current Trends and Future Directions
Prof. Jacques Galipeau, Associate Dean for Therapeutics Development University of Wisconsin School of Medicine and Public Health, University of Wisconsin in Madison, USA

• T cell receptors and MHC diversity in risk, prognosis, and therapy for gliomas
A/Prof. Gary Kohanbash, Director, PNIO Laboratory, Faculty of the Department of Neurological Surgery at UPMC Children’s Hospital of Pittsburgh, USA

• Novel pans solid tumor CAR T cells and first in human trial in DIPG
Assoc. Prof. Supannikar Tawinwung, Cellular Immunotherapy Research Unit, Chulalongkorn University; Facility Director, Cell and Gene Therapy Manufacturing Center, King Chulalongkorn Memorial Hospital, Thailand

• HSCT: An update
Dr. Dianne De Santis, Senior Medical Scientist, Department of Clinical Immunology, PathWest, Royal Perth Hospital, Australia

• Saving Lives Across Borders: The Asia-Pacific Unrelated Stem Cell Donor Registry Experience
Pawinee Kupatawintu, National Blood Center, the Thai Red Cross Society, Thailand
Prof. Ram Mohan Jaiswal, Mahatma Gandhi Medical College & Hospital, India
Garth Healey, Australian Bone Marrow Donor Registry, Australia

• HLA in Diseases Susceptibility and Personalized Medicine
Prof. Katsushi Tokunaga, Director, Genome Medical Science Project, Research Institute,
National Center for Global Health and Medicine (NCGM); Director,
Central Biobank, National Center Biobank Network (NCBN), Japan

• Clinical implementation of HLA long-read sequencing
A/Prof. Pajaree Chariyavilaskul, Center of Excellence in Clinical Pharmacokinetics and Pharmacogenomics, Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Thailand

• HLA Typing and Beyond with Nanopore Sequencing
Dr. Thidathip Wongsurawat, Head Division of Medical Bioinformatics, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand

• Beyond Traditional HLA Typing: NGS and HLA Imputation for Comprehensive Analysis of HLA Alleles in Thai SLE Patients
Dr. Charles Khor Seik-Soon, Singapore Centre for Environmental Life Sciences Engineering, Nanyang Technological University, Singapore

• Improving The Efficiency And Reliability Of Post-Transplantation Monitoring And Prognosis with Donor-Derived Cell-Free DNA (dd-cfDNA)

• HLA typing using Nanopore with Automation

• Implementation of Virtual Crossmatching in Australia: the laboratory experience
Fiona Hudson, Senior Scientist at VTIS, Melbourne, Australia

• Determining compatibility in Solid Organ Transplantation – Challenges and Opportunities
Rhonda Holdsworth HLA Specialist and Clinical Scientist Specialist Advisor, Transplantation and Immunogenetics Services Pathology and Clinical Governance Division, Australian Red Cross Lifeblood, Australia

• Non-HLA antibodies in solid organ transplant
Dr. Lucy Sullivan, Scientific Director at Australian Red Cross LifeBlood, Australia

• Case Studies for Complex Patients
Assoc. Prof. Duangtawan Thammanichanond, Histocompatibility and Immunogenetics Laboratory, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand
Assoc. Prof. Natavudh Townamchai, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, Thailand
Dr. Mary Diviney, Senior Clinical Scientist / Manager, Victorian Transplantation and Immunogenetics Service (VTIS), Australian Red Cross Lifeblood, Australia
Asst. Prof. Peenida Skulratanasak Division of Nephrology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand

• Expanding Access to Transplantation: Utilization of A2 Kidneys for O and B Recipients
Dr. Cathi Murphey, Director, Histocompatibility and Immunogenetics Laboratory, Southwest Immunodiagnostics, Inc.. San Antonio, USA

• Management of Highly sensitized kidney transplant recipients
Prof. Jaeseok Yang, Division of Nephrology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital; Laboratory of Transplantation Immunology, Yonsei University Severance Hospital, Korea
Prof. Yingyos Avihingsanon, Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, Thailand